Portfolio (Quarterly)
Guide ↗
Remedium Capital Partners, LLC
· CIK 0002104501| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics Inc | Healthcare | 1,565,661.0 | $76.8M | 27.32% | +13K | +0.8% | $49.05 | +38.0% |
| 2 | — | Damora Therapeutics Inc | — | 2,045,473.0 | $53.0M | 18.84% | +1.9M | +1597.9% | $25.90 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%